Low dose corticosteroids and theophylline in the treatment of COPD

Funding Activity

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Chronic obstructive pulmonary disease is an inflammatory disease the lungs which will be the 3rd most common cause of death in 2020. Treatment is expensive and inaccessible for many patients in developing countries. This study will look at the clinical effectiveness of two cheap drugs which, when used in combination, have been shown to act together to reduce the inflammation in this disorder. A positive outcome would revolutionise treatment in the developing world.

Funded Activity Details

Start Date: 01-01-2012

End Date: 01-01-2017

Funding Scheme: Project Grants

Funding Amount: $2,840,369.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Clinical Pharmacology and Therapeutics

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

chronic obstructive pulmonary disease (COPD) | clinical pharmacology | clinical trial | corticosteroids | respiratory diseases